Agios Pharma (AGIO) PT Raised to $90 at RBC Capital

May 7, 2018 7:39 AM EDT Send to a Friend

RBC Capital raised its price target on Agios Pharma (NASDAQ: AGIO) to $90.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Agios Pharma (AGIO) PT Raised to $90 at RBC Capital

Member Login

Free News Feed